Foretinib is effective in acute myeloid leukemia by inhibiting FLT3 and overcoming secondary mutations that drive resistance to quizartinib and gilteritinib
Article in Cancer Research (January 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Cancer Research (January 2024)
Article in Cancers (September 2023)
Article in American Journal of Cancer Research (March 2023)